The TGA is conducting a public consultation on the TGA's proposed increase to fees and charges for the 2022-23 financial year by an indexation factor of 2.60%.
This technical alert provides information on the TGA Fees and Charges Proposal 2022-23, including on a proposal to apply new fees for variations on Clinical Trial Approval (CTA) schemes.
The TGA have expressed a preference for consolidated feedback from your industry body (CMA). Members are asked to provide any feedback to the consultation to CMA by Mon 238 Feb 2022 via technical@cmasutralia.org.au.